FO
FT Options Portfolio holdings
AUM
$40M
This Quarter Return
-3.32%
1 Year Return
+13.03%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$68M
AUM Growth
+$68M
(-16%)
Cap. Flow
-$10.5M
Cap. Flow
% of AUM
-15.5%
Top 10 Holdings %
Top 10 Hldgs %
55.84%
Holding
220
New
38
Increased
14
Reduced
19
Closed
48
Top Buys
| 1 |
JPMorgan Chase
JPM
|
$3.58M |
| 2 |
Constellation Brands
STZ
|
$3.07M |
| 3 |
General Mills
GIS
|
$2.28M |
| 4 |
Gilead Sciences
GILD
|
$2.21M |
| 5 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$2M |
Top Sells
| 1 |
Procter & Gamble
PG
|
$4.04M |
| 2 |
Bristol-Myers Squibb
BMY
|
$3.97M |
| 3 |
CASC
Cascadian Therapeutics, Inc.
CASC
|
$3.19M |
| 4 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$2.56M |
| 5 |
iShares Biotechnology ETF
IBB
|
$2.03M |
Sector Composition
| 1 | Healthcare | 57.22% |
| 2 | Consumer Staples | 17.99% |
| 3 | Consumer Discretionary | 5.6% |
| 4 | Financials | 5.26% |
| 5 | Communication Services | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Regeneron Pharmaceuticals
REGN
$61.3B
| $9.79M | 11.24% |
26,665
-323
| -1% | -$119K |
|
2
Abbott
ABT
$229B
| $5.68M | 6.53% |
147,970
-3,665
| -2% | -$141K |
|
|
3
JPMorgan Chase
JPM
$824B
| $3.58M | 4.11% |
+41,500
| New | +$3.58M |
|
4
Akebia Therapeutics
AKBA
$825M
| $3.53M | 4.05% |
338,640
-27,478
| -8% | -$286K |
|
|
5
Gilead Sciences
GILD
$140B
| $3.38M | 3.88% |
47,227
+30,806
| +188% | +$2.21M |
|
|
6
General Mills
GIS
$26.4B
| $3.37M | 3.86% |
54,477
+36,971
| +211% | +$2.28M |
|
|
7
Constellation Brands
STZ
$26.7B
| $3.07M | 3.52% |
+20,000
| New | +$3.07M |
|
|
ALXN
8
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2M | 2.3% |
+16,335
| New | +$2M |
|
|
OTIC
9
DELISTED
Otonomy, Inc.
OTIC
| $1.88M | 2.16% |
118,473
-20,612
| -15% | -$328K |
|
|
POT
10
DELISTED
Potash Corp Of Saskatchewan
POT
| $1.72M | 1.98% |
95,080
| – | – |
|
|
TWX
11
DELISTED
Time Warner Inc
TWX
| $1.68M | 1.93% |
+17,386
| New | +$1.68M |
|
|
PNRA
12
DELISTED
Panera Bread Co
PNRA
| $1.28M | 1.47% |
+6,243
| New | +$1.28M |
|
13
AbbVie
ABBV
$374B
| $1.25M | 1.43% |
+19,886
| New | +$1.25M |
|
14
Kimberly-Clark
KMB
$42.7B
| $1.16M | 1.33% |
+10,150
| New | +$1.16M |
|
|
MNK
15
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $1.11M | 1.27% |
22,200
+17,196
| +344% | +$857K |
|
16
Rocket Pharmaceuticals
RCKT
$350M
| $1.11M | 1.27% |
181,172
+24,308
| +15% | +$148K |
|
|
RDUS
17
DELISTED
Radius Health, Inc.
RDUS
| $1.07M | 1.23% |
28,116
+2,363
| +9% | +$89.8K |
|
18
Target
TGT
$42B
| $1.05M | 1.2% |
+14,502
| New | +$1.05M |
|
|
SE
19
DELISTED
Spectra Energy Corp Wi
SE
| $992K | 1.14% |
+24,150
| New | +$992K |
|
20
Clorox
CLX
$14.7B
| $944K | 1.08% |
+7,862
| New | +$944K |
|
|
CMRX
21
DELISTED
Chimerix, Inc.
CMRX
| $944K | 1.08% |
205,266
| – | – |
|
22
Biogen
BIIB
$20.5B
| $905K | 1.04% |
+3,191
| New | +$905K |
|
|
SAGE
23
DELISTED
Sage Therapeutics
SAGE
| $816K | 0.94% |
15,978
+3,200
| +25% | +$163K |
|
24
Sarepta Therapeutics
SRPT
$1.77B
| $797K | 0.92% |
29,074
-19,951
| -41% | -$547K |
|
|
CASC
25
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $766K | 0.88% |
177,829
-739,746
| -81% | -$3.19M |
|